A prospective cohort study of the impact of outpatient Intensive Cardiac Rehabilitation on depression and cardiac self-efficacy.
Cardiac self-efficacy
Cardiovascular disease
Depression
Intensive Cardiac Rehabilitation
Journal
American heart journal plus : cardiology research and practice
ISSN: 2666-6022
Titre abrégé: Am Heart J Plus
Pays: United States
ID NLM: 101779333
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
entrez:
21
11
2022
pubmed:
22
11
2022
medline:
22
11
2022
Statut:
ppublish
Résumé
To evaluate whether an Intensive Cardiac Rehabilitation (ICR) program improves depression and cardiac self-efficacy among patients with a qualifying cardiac diagnosis. Prospective, longitudinal cohort design. Single-center, tertiary referral, outpatient cardiac rehabilitation center. Patients with a qualifying diagnosis for ICR. Outpatient ICR. Mental health, as assessed using the Patient Health Questionnaire-9 (PHQ-9) and cardiac self-efficacy using the Cardiac Self-Efficacy (CSE) scale. Of the 268 patients included (median age 69 y, 73% men), 70% had no depressive symptoms at baseline (PHQ-9 score <5). PHQ-9 scores improved in the overall sample (p < 0.0001), with greater improvements among patients with mild depressive symptoms at baseline (-4 points, p < 0.001) and those with moderate to severe depressive symptoms at baseline (-5.5 points, p < 0.001). Cardiac self-efficacy improved overall, and the two subsections of the cardiac self-efficacy questionnaire titled, "maintain function" and "control symptoms" improved (all p < 0.001). Participation in an outpatient ICR program is associated with fewer depressive symptoms and greater cardiac self-efficacy among patients with CVD who qualify for ICR. The improvement in depression was greatest for those with moderate to severe depressive symptoms.
Identifiants
pubmed: 36407054
doi: 10.1016/j.ahjo.2022.100100
pmc: PMC9671388
mid: NIHMS1849761
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIA NIH HHS
ID : R01 AG060499
Pays : United States
Organisme : NHLBI NIH HHS
ID : R21 HL145217
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL130357
Pays : United States
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
PLoS One. 2020 Nov 18;15(11):e0242326
pubmed: 33206691
Brain Sci. 2021 May 29;11(6):
pubmed: 34072605
Am J Med. 2007 Sep;120(9):799-806
pubmed: 17765050
J Public Health Afr. 2018 Dec 21;9(3):826
pubmed: 30854176
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Front Psychiatry. 2018 Jan 23;9:1
pubmed: 29410632
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Eur Respir J. 2011 Jan;37(1):150-6
pubmed: 20525717
CNS Neurosci Ther. 2020 Sep;26(9):885-895
pubmed: 32491278
Nat Rev Cardiol. 2017 Mar;14(3):145-155
pubmed: 27853162
Am J Cardiol. 1997 Apr 15;79(8):1112-4
pubmed: 9114776
Mindfulness (N Y). 2021;12(12):3047-3059
pubmed: 34630733
Eur J Cardiovasc Nurs. 2015 Dec;14(6):536-43
pubmed: 25149667
J Cardiometab Syndr. 2006 Fall;1(5):308-12
pubmed: 17679787
Health Psychol. 2009 Mar;28(2):166-73
pubmed: 19290708
Trends Cardiovasc Med. 2015 Oct;25(7):614-22
pubmed: 25850976
Clinics (Sao Paulo). 2019 Sep 26;74:e1017
pubmed: 31576916
Med Care. 2004 Dec;42(12):1194-201
pubmed: 15550799
Aging Ment Health. 2020 Dec;24(12):1956-1962
pubmed: 31290680
Ochsner J. 2007 Winter;7(4):167-72
pubmed: 21603539
Psychosom Med. 1998 Jul-Aug;60(4):473-8
pubmed: 9710293